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Abstract 
Background: A targeted malaria elimination project, including mass drug administrations (MDA) of dihydroarte-
misinin/piperaquine plus a single low dose primaquine is underway in villages along the Thailand Myanmar border. 
The intervention has multiple components but the success of the project will depend on the participation of the 
entire communities. Quantitative surveys were conducted to study reasons for participation or non-participation in 
the campaign with the aim to identify factors associated with the acceptance and participation in the mass drug 
administrations.
Methods: The household heads in four study villages in which MDAs had taken place previously were interviewed 
between January 2014 and July 2015.
Results: 174/378 respondents (46 %) completed three rounds of three drug doses each, 313/378 (83 %) took at least 
three consecutive doses and 56/378 (15 %) did not participate at all in the MDA. The respondents from the two vil-
lages (KNH and TPN) were much more likely to participate in the MDA than respondents from the other two villages 
(HKT and TOT). The more compliant villages KNH and TPN had both an appearance of cohesive communities with 
similar demographic and ethnic backgrounds. By contrast the villages with low participation were unique. One village 
was fragmented following years of armed conflict and many respondents gave little inclination to cooperate with 
outsiders. The other village with low MDA coverage was characterised by a high percentage of short-term residents 
with little interest in community interventions. A universal reason for non-participation in the MDA applicable to all 
villages was an inadequate understanding of the intervention.
Conclusions: It is unlikely that community engagement can unite fragmented communities in participating in an 
intervention, which benefits the community. Understanding the purpose and the reasons underlying the intervention 
is an important pre-condition for participation. In the absence of direct benefits and a complete understanding of the 
indirect benefits trust in the investigators is critical for participation.
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Background
Economic development, deforestation and on-going 
malaria control activities including the distribution of 
insecticide-treated bed nets (ITNs) and improved man-
agement have reduced malaria prevalence to historically 
low levels in the Greater Mekong Subregion (GMS). The 
recent emergence and spread of artemisinin resistance 
in Western Cambodia is a threat for the effective treat-
ment of falciparum malaria [1]. In the absence of alter-
native first-line anti-malarial drugs increasing falciparum 
malaria related morbidity and mortality can be expected. 
The interruption of malaria transmission is the remaining 
best strategy to stop the spread of artemisinin-resistant 
Plasmodium falciparum, which requires the elimination 
of all falciparum infections including the submicroscopic 
parasite reservoir. The large majority of parasitaemia 
people in low transmission settings have no clinical signs 
or symptoms of malaria hence screening with rapid diag-
nostic tests, microscopy and even standard PCR misses 
a proportion of infections [2]. Targeted malaria elimina-
tion includes mass drug administrations (MDA) for the 
presumptive treatment of all residents in foci of high 
sub-microscopic infections in addition to improved case 
management by village health workers and the distribu-
tion of ITNs.
Mass administrations of anti-malarial drugs have been 
recorded and reported for more than a century [3]. Well-
conducted campaigns have interrupted malaria trans-
mission for extended periods [4] and permanently in 
an island setting (Aneityum, Vanuatu) [5]. Public health 
interventions depend on the goodwill and support of the 
community [6]. Mass administrations of anti-malarial 
drugs differ fundamentally from other interventions in 
that the participation of the entire community is essen-
tial for success. Non-participants can become a residual 
reservoir for infections, continue to transmit malaria 
and thus prevent elimination. There has been extensive 
research on the pharmacokinetics, dynamics, and effi-
cacy of various anti-malarial drug regimens [7]. Less is 
known about the factors, which influence community 
acceptance or refusal to participate in mass administra-
tions of anti-malarial drugs.
Newby and co-workers conducted a systematic lit-
erature review of mass administrations of anti-malar-
ial drugs in 2014 [3]. Very few of the articles provided 
detailed descriptions of knowledge, attitudes and percep-
tions towards mass administrations or a description of 
efforts to engage the community and increase participa-
tion. Examples for continued research on the acceptance 
of anti-malarial mass drug administration campaigns 
come from Aneityum Island [8, 9] and The Gambia [10–
12]. One such report described a quantitative survey fol-
lowing a mass administration of anti-malarials conducted 
in The Gambia in 1998/99 [10]. Individuals who believed 
in the importance of the MDA and those who were aware 
that a high level of participation was needed for the MDA 
to be successful were more likely to participate.
Understanding that the purpose of the MDA was to 
reduce malaria, knowledge of the fact that malaria is 
transmitted by mosquitoes and awareness of the clini-
cal signs of malaria were associated with participation. 
Individuals who discussed the MDA with other villagers 
and those who attended the sensitization meeting were 
also more likely to participate than those who did not. 
In The Gambia women were significantly more likely 
than men to participate in the mass drug administra-
tions. The investigators concluded that better informa-
tion could lead to increased participation in their target 
populations in rural West Africa. In 2013, 14 years after 
the campaign, social scientists re-visited the study site 
in The Gambia and interviewed the population about 
this and subsequent mass drug administrations targeting 
trachoma transmission [11]. This later qualitative study 
found that timing of the campaign, accurate informa-
tion on the procedures, drug regimen, and possible side 
effects were critical for participation. The authors con-
cluded that continuous sensitization meetings may be 
needed to achieve high coverage. In 2014 a second mass 
administration of anti-malarial drugs was conducted in 
The Gambia. A combined quantitative and qualitative 
study explored the motivations and circumstances for 
non-uptake and non-adherence [12]. This time the most 
frequently mentioned reasons for non-participation were 
mobility/travel, fear of drug reactions, inconvenience and 
insufficient information.
A targeted malaria elimination project is currently 
underway in villages along the Thailand–Myanmar bor-
der. Quantitative surveys were conducted to study rea-
sons for participation or non-participation in the drug 
administration campaign with the aim to identify factors 
associated with acceptance of the complete drug admin-
istration, three rounds of three doses of anti-malarials, 
part of the drug administration or no participation at all.
Methods
The villages
Four Karen villages (HKT, KNH, TOT, and TPN) located 
within 10  km of the Thailand Myanmar border were 
selected for inclusion in a targeted malaria elimina-
tion project based on the prevalence of P. falciparum 
parasitaemia detected by high volume ultrasensitive real 
time polymerase chain reaction (uPCR) [2, 13]. Briefly 
the overall population in the four villages is 2377 (HKT 
908, KNH 349, TOT 745, and TPN 375). Using uPCR 
520 (34  %) of 1536 people who participated in an ini-
tial survey were infected [P. falciparum 87/1536 (6  %), 
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Plasmodium vivax 230/1536 (15  %), mixed infections 
21/1536 (1  %), and Plasmodium species 182 (12  %)]. 
142/152 (93 %) participants with P. falciparum infections 
and 309/323 (96 %) with P. vivax infections were asymp-
tomatic on the day of the survey [13]. The study popu-
lation consists of three major ethnicities (Burman, Pow 
Karen, and Sgaw Karen).
Like many ethnic groups in Myanmar, the Karen, have 
been involved in conflicts with the central government 
since independence in 1949. The Karen National Lib-
eration Army (KNLA) was the main force in Karen State 
until 1994 when other Karen groups were formed such 
as the Democratic Karen Buddhist Army (DKBA). Karen 
villagers in the conflict zones of Eastern Karen State have 
usually no representation in the central Myanmar gov-
ernment nor does the central government have a stable 
presence in the study villages. This complex and unstable 
geo-political situation has affected the lives of villagers in 
this area and is strongly felt in villages where sometimes 
opposing groups continue to coexist. Despite recent ces-
sation of armed hostilities, these factors have contributed 
to the deterioration of the social fabric. This was most 
evident in TOT where strong contingents of KNLA and 
DKBA rule different sections of the village. HKT used 
to be a small settlement but has grown into trading post 
over the last decade with a relatively large population of 
shopkeepers and their relatives, none of whom are Karen.
The intervention
After approval from regional and village leaders a series 
of village meetings were conducted. All members of 
the target population were invited to participate in the 
drug administration with the exception of infants under 
6 months of age and pregnant women in the 1st trimes-
ter. To assure that pregnant women in the 1st trimester 
did not participate the entire population was reminded 
of the exclusion criteria at each meeting. Women unsure 
about their pregnancy status were offered rapid preg-
nancy tests free of cost. The methods and purpose of the 
campaign were explained and questions were answered. 
To engage the community in the study which included 
multiple blood draws [13] besides the drug administra-
tion the investigators pledged to provide a community 
incentive. Based on discussions with the villagers the 
study team facilitated the installation of an improved 
water supply system for the benefit of the entire vil-
lage (Fig. 1). The primary health care centres where the 
intervention was delivered were rehabilitated and refur-
bished or newly established if no appropriate structure 
was available. House to house visits were conducted to 
inform and invite all eligible residents to participate in 
the drug administration. A multifaceted programme 
was offered to the villagers at a central place, usually 
the primary health care centre explaining the transmis-
sion and pathogenesis of malaria as well as the rational 
and methods of the planned drug administration as 
well as other methods to prevent malaria. These small 
group meetings included a drama-show scripted by the 
community engagement team and a display of posters 
designed by the team. Additional projects such as meet-
ings and children activities were organised in the schools. 
Participants received snacks and refreshments during the 
meetings. No individual monetary incentives were pro-
vided for participants in the MDA.
Three rounds of the anti-malarial drugs were given 
1 month apart. Each round consisted of three daily doses 
of dihydroartemisinin/piperaquine plus a single low dose 
primaquine (0.25  mg/kg). The first MDAs in TOT and 
KNH took place between April and July 2013 and the 
second set between December 2013 and April 2014. The 
drugs were administered under direct observation. The 
drug regimen is illustrated in Fig.  2. Following the drug 
administrations the residents in intervention and control 
villages were under fever surveillance for a 24  months 
period. All villagers were asked to participate in 3-monthly 
surveys to detect submicroscopic parasitaemia by uPCR. 
Between surveys a village health worker diagnosed using 
rapid diagnostic tests and treated malaria episodes. Due to 
lower than expected coverage the residents of TOT were 
offered an opportunity to participate in a second MDA 
between April and June 2015. The timing of the interviews 
in relation to the MDAs is illustrated in Fig. 3.
The interviews
A structured instrument was developed, based on the 
questionnaire used in The Gambia in 1999 [10]. The 
investigators translated the questionnaire into local 
languages and adapted the instrument to local circum-
stances. After piloting and finalization of the ques-
tionnaire interviewers who were not members of the 
sensitisation team and did not participate in other 
aspects of the intervention, conducted the interviews. 
Fig. 1 Three water storage tanks were installed by the study team 
covered by a corrugate iron roof, which are a part of the improved 
water supply system provided as a community incentive to the vil-
lage in the background
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The aim was to interview the household heads or their 
representatives in each household in each study village. 
In case the household head could not be interviewed 
after repeated attempts the next senior household mem-
ber was interviewed. The first sets of interviews were 
conducted in TOT, KNH, and TPN in January and Feb-
ruary 2014. A second set of interviews was conducted in 
June 2015 in HKT and in TOT following the completion 
of a second MDA in that village. The timing of the inter-
views in relation to the drug administration campaigns is 
illustrated in Fig. 3.
Data management and analysis
The responses were recorded on paper questionnaires, 
translated into English and single entered in Microsoft 
Access (Access version 14, Microsoft, Redmond, Wash-
ington, USA). The number of DHA/piperaquine doses 
received by each respondent was based on the data col-
lected by the drug administration team. The files were 
linked using unique identification numbers assigned to 
each household member and used by both interviewer 
and drug administration teams.
For the purposes of this acceptance study respond-
ents who did not participate in the MDA (i.e. did not 
take a single dose) were defined as non-participants. 
This group of non-participants may have been absent or 
completely refused participation. In a secondary analysis 
respondents who did not participate in a single complete 
round (three consecutive doses) necessary to clear para-
sitaemia completely were considered non-participants. 
People who took at least one dose but less than nine 
doses were defined as incomplete participants, and peo-
ple who took three rounds of three doses each (i.e. nine 
doses) were defined as complete participants. The inges-
tion of a single low dose primaquine with each round of 
DHA-piperaquine was not included in the definitions of 
participation.
Normally distributed data were analysed using the 
Chi squared test or Fisher’s exact test as appropriate. 
Non-parametric continuous data were analysed using 
Kruskal–Wallis equality-of-populations rank test or 
Mann–Whitney test as appropriate. Considering the 
number of variables and hypotheses tested only a con-
servative p  <  0.01 was considered significant. A logistic 
regression model was constructed to identify variables 
independently associated with the participation in three 
rounds of three doses DHA piperaquine (i.e. complete 
participation). For this purpose the respondents were 
re-categorised into complete participants who took nine 
doses DHA-piperaquine or respondents who took less 
Fig. 2 A schematic representation of treatment regimen in targeted malaria elimination (TME)
Fig. 3 The approximate timing of the interviews (INT) in relation to mass drug administrations (MDA). The interviews were usually completed in the 
less than a week while the completion of three rounds of MDAs required 3 months
Page 5 of 12Kajeechiwa et al. Malar J  (2016) 15:494 
than nine doses. Only responses collected during the 
first set of interviews in TOT in 2014 were included in 
the models due to the high correlation between sequen-
tial responses in the same household. The final model 
was adjusted for the significant variables in the univariate 
analysis. All analyses were performed using Stata, version 
14 (StataCorp, College Station, TX, USA).
Results
Background and demographics
388 respondents were interviewed. The participation status 
in the mass drug administration of 378/400 respondents 
(97  %) was documented in the database. Overall 313/378 
respondents (83 %) took at least three consecutive doses of 
the anti-malarials required for the complete clearance of par-
asites. 174/378 respondents (46 %) completed three rounds 
of three drug doses each, 56/378 (15 %) did not participate 
at all, and the remaining 148 (39 %) respondents participated 
but did not complete the full course of 9 doses (Table 1).
The participation of respondents in the MDA var-
ied significantly between villages (Fig. 4). In KNH 72/75 
(96  %) of the respondents took at least three consecu-
tive doses of anti-malarials, in TPN 63/66 (95 %), and in 
HKT 87/123 (81 %). During the first drug administration 
in 2013 in TOT 91/114 (80 %) respondents took at least 
three doses. During a second MDA in 2015 the number 
of respondents who took at least three doses was not sig-
nificantly lower 76/105 (73 %; p = 0.2).
The respondents identified with four main ethnicities 
Sgaw, Burman, and Poe. A significantly larger propor-
tion of Burmans (21/88, 24 %) did not participate in the 
MDA than members of other ethnicities (Sgaw 23/172, 
14 %; Paw 11/108; 10 %; p < 0.002). The ethnicity varied 
between villages; the large majority of the respondents 
in TOT (88 %; 100/114) were Sgaw and Burman in HKT 
(58  %; 71/123). Literacy was overall 59  % (223/378) but 
varied significantly between villages. 75 % (56/75) of the 
respondents in KNH, 73 % (95/131) in HKT, 66 % (45/68) 
Table 1 Demographics, education and profession of respondents in relation to participation
Responses are sorted by totals; with the exception of the first row percentages % refer to columns not rows
MDA mass drug administration, NA not applicable
* Chi squared test or Fisher’s exact test
** Kruskal–Wallis equality-of-populations rank test
a 2014
No MDA % Incomplete MDA % Complete MDA % Total p value*
Number respondents 56 15 % 148 39 % 174 46 % 378 100 % NA
Sex
 Female 39 70 % 111 75 % 125 72 % 284 73 %
 Male 17 30 % 36 25 % 46 26 % 107 26 %
 No answer 0 1 1 % 3 2 % 4 1 % 0.99
 Age (mean in years) 39 39 40 39 0.79**
Village
 HKT 34 61 % 52 35 % 37 22 % 123 33 %
 TOTa 19 34 % 59 40 % 36 21 % 114 30 %
 KNH 2 4 % 15 10 % 58 33 % 75 20 %
 TPN 1 2 % 22 15 % 43 25 % 66 18 % <0.001
Ethnicity
 Sgaw 23 41 % 76 51 % 73 42 % 172 46 %
 Paw 11 20 % 31 21 % 66 38 % 108 29 %
 Burman 21 38 % 38 26 % 29 17 % 88 23 %
 Other 1 2 % 2 1 % 5 3 % 8 2 %
 No answer 0 1 1 % 1 1 % 1 % 0.002
Literacy
 Yes 36 64 % 82 55 % 105 60 % 223 59 % 0.457
Profession
 Farmer 33 59 % 94 64 % 110 63 % 237 63 % 0.818
 Other 7 13 % 35 24 % 39 22 % 81 21 % NA
 Shopkeeper 15 27 % 14 9 % 13 7 % 42 11 % 0.008
 Forest worker 1 2 % 5 3 % 12 7 % 18 5 % 0.349
Page 6 of 12Kajeechiwa et al. Malar J  (2016) 15:494 
in TBN but only 30  % (34/114) in TOT (p  <  0.001) 
reported that they could read and write.
The majority of respondents (237/378, 63 %) stated to 
be farmers. Other professions included shopkeeper, for-
estry, retired, tailor, healer, and others. People who con-
sidered themselves as shopkeepers were significantly less 
likely to participate in the MDA (15/42, 36 %; p = 0.008). 
24/42 (57 %) of respondents who stated they were shop-
keepers resided in HKT.
Perceptions of health and malaria specifically
The large majority (295/378; 78  %) of respondents 
stated unprompted that malaria caused the most health 
problems in their village followed by respiratory tract 
infections (56/378; 15  %), diarrhoea (31/378; 8  %) and 
tuberculosis (6/378; 2  %; Table  2). Eighty nine percent 
(59/66) of the respondents in TPN and 85 % (104/123) in 
HKT but only 61 % (69/113) in TOT stated that malaria 
caused most health problems (p < 0.001).
277/378 (73 %) respondents knew that malaria is trans-
mitted by mosquitoes, while 61/378 (16 %) respondents 
did not know how malaria was transmitted (Table  2). 
Respondents who didn’t know the causes of malaria were 
less likely to participate in the MDA than respondents 
who knew (p = 0.001). Ninety one percent (68/75) of the 
respondents in KNH, 80 % (98/123) of the respondents in 
HKT, 83 % (55/66) in TPN were aware of the role of mos-
quitoes in malaria transmission but only 49 % (56/114) in 
TOT (p < 0.001).
Three quarters (282/378; 75  %) of the respondents 
stated unprompted that they used bed nets to prevent 
malaria. Less than 10  % of the respondents mentioned 
other methods to prevent malaria such as mosquito 
coils, cutting grass around the house, or spraying of 
insecticides (Table 2). Eighty nine percent (67/75) of the 
respondents in KNH, 76  % (93/123) in HKT but only 
62 % (70/113) of the respondents in TOT stated they are 
using bed nets to prevent malaria (p < 0.001).
The malaria symptoms most frequently mentioned by 
the respondents were: shivering (180/378, 48  %), fever 
(177/378, 47 %), headache (175/378, 46 %), and vomiting 
94/378, 25 %). There was a statistically significant associa-
tion between recognizing headache as a potential malaria 
symptom and participation in the MDA (p  =  0.001). 
There was no statistically significant difference in the 
proportion of respondents who mentioned fever and 
shivering as symptoms of malaria between the four vil-
lages but more respondents in HKT and TPN than in 
TOT and KNH knew that malaria can present with head-
ache and vomiting (p = 0.001).
Understanding the intervention
Eighty five percent (322/378) respondents understood 
that the purpose of the campaign was to protect against 
malaria. More than 90  % of the respondents in TPN 
(62/66) and HKT (113/123) apparently understood this 
concept but only 70 % (80/114) in TOT (P < 0.001).
The large majority of the respondents indicated that 
they understood the concept of symptomatic and asymp-
tomatic malaria (Table  3). 224/378 respondents (59  %) 
correctly agreed that that it can be difficult to iden-
tify asymptomatic infected people and 292/378 (77  %) 
agreed that asymptomatic people can transmit malaria by 
infecting mosquitoes. This last concept was understood 
by 88  % (58/66) of the respondents in TPN and 87  % 
(107/123) of respondents in HKT but only 63 % (71/112) 
of respondents in TOT (p < 0.001).
Reassuringly only a single respondent felt that the par-
ticipation in the MDA would replace the need for a bed 
net to protect against mosquito bites.
Perceptions of the campaign
Most respondents (219/266; 86 %) agreed that it is impor-
tant that everybody in the village should participate in 
the intervention irrespective whether the respondent 
participated or not. Respondents who participated were 
significantly more likely to state that they had received 
sufficient information about the campaign (p  <  0.001, 
Table 4). Perhaps not surprisingly participants were also 
significantly more likely to recommend the program to 
others than non-participants.
Independent factors associated with participation in the 
MDA
A multivariate logistic regression model identified two 
factors which were independently associated with par-
ticipation in the MDA (Table  5). Respondents living 
in KNH and TPN were significantly more likely to par-
ticipate than respondents from HKT or TOT. Secondly 
respondents who felt they had received sufficient infor-
mation about the campaign were significantly more likely 
Fig. 4 Percentage of respondents who did not participate in the 
MDA by village (and year of mass drug administration in TOT)
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Table 2 Health perceptions in relation to participation
The table shows the number of respondents who mentioned an answer unprompted. The statistical comparison is between people who mentioned and who didn’t 
mention an answer. Responses are sorted by totals, percentages % refer to columns not rows
* Chi squared test or Fisher’s exact test
MDA administration p value*
No Incomplete Complete Total
Number respondents (56) (148) (174) (378)
What sickness causes most health problems in your village? (more than one answer was allowed)
 Malaria 42 75 % 116 78 % 137 79 % 295 78 % 0.978
 Respiratory tract infections 9 16 % 23 16 % 24 14 % 56 15 % 0.065
 Diarrhoea 5 9 % 12 8 % 14 8 % 31 8 % 0.871
 Tuberculosis 0 0 % 1 1 % 5 3 % 6 2 % 0.302
What causes malaria? (more than one answer was allowed)
 Mosquitoes transmit malaria 44 79 % 96 65 % 137 79 % 277 73 % 0.012
 Don’t know 7 13 % 37 25 % 17 10 % 61 16 % 0.001
 No answer 5 9 % 15 10 % 20 11 % 40 11 %
What do you do to prevent malaria? (more than one answer was allowed)
 Use bed net 38 68 % 107 72 % 137 79 % 282 75 % 0.140
 Use mosquito coils 4 7 % 13 9 % 16 9 % 33 9 % 0.854
 Cut down the grass 6 11 % 5 3 % 16 9 % 27 7 % 0.249
 Spray household with insecticide 4 7 % 8 5 % 8 5 % 20 5 % 0.178
 No answer 4 7 % 15 10 % 0 19 5 %
What kind of complaints do people with malaria have? (more than one answer was allowed)
 Shivering 26 46 % 69 47 % 85 49 % 180 48 % 0.376
 Fever 30 54 % 76 51 % 71 41 % 177 47 % 0.268
 Headache 25 45 % 64 44 % 86 49 % 175 46 % 0.001
 Vomiting 14 25 % 36 24 % 44 25 % 94 25 % 0.046
Table 3 Understanding the intervention in relation to participation
The table shows the number of respondents who agree with the answer. The statistical comparison is between people who answered “yes” and people who didn’t. 
Responses are sorted by totals
* Chi squared test
MDA administration
No Incomplete Complete Total p value*
Number respondents (56) (148) (174) (378)
What did you learn and understand during the sensitisation meetings? (more than one answer was allowed)
 Many people who get malaria become sick 49 88 % 125 84 % 159 91 % 333 88 % 0.151
 Individuals can have malaria infections and feel perfectly well 16 29 % 63 43 % 81 47 % 324 43 % 0.038
 Malaria is more common in the rainy season 42 76 % 114 78 % 146 85 % 305 81 % 0.857
Mosquitoes may become infected from biting individuals who do not get sick 44 80 % 111 75 % 137 79 % 292 78 % 0.672
 It is difficult to tell which individuals are carrying malaria without getting sick 36 64 % 92 62 % 96 55 % 224 59 % 0.281
 Nothing 1 2 % 1 1 % 1 1 % 3 1 % 0.531
What do you think the medicine is for?
 Protection from malaria 43 77 % 122 82 % 157 90 % 322 85 % 0.023
 Gives me strength/energy 1 2 % 8 5 % 8 5 % 17 4 % 0.536
 Mosquitoes will not be able to bite me 1 2 % 5 3 % 4 2 % 10 3 % 0.759
 After taking the medicine I will not need to sleep under my bed net 0 0 % 1 1 % 0 0 % 1 0 % 0.459
 No answer 11 20 % 12 8 % 5 3 % 28 7 %
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to participate than respondents who didn’t have this 
impression.
Comparing reasons for non‑participation
The reasons for non-participation are compared between 
three villages TOT, KNH, and TPN as well as following a 
second MDA in in TOT in 2015 (no data for HKT avail-
able; Fig. 5). In all villages the most frequently mentioned 
reason for non-participation was absence from the village 
at the time of the campaign. 12/19 (63  %) respondents 
who didn’t participate in TOT in 2013 used this explana-
tion compared to only 4/21 (19 %) respondents in 2015 
(p < 0.001). Also distrust which was mentioned by 8/19 
(42 %) of participants in 2013 had dropped to 3/21 (14 %) 
by 2015 (p = 0.05).
Changes in malaria knowledge in TOT between 2014 
and 2015
The respondents’ understanding of the intervention and 
knowledge of malaria had overall improved between the 
first set of interviews was conducted in TOT in Febru-
ary 2014 and the second set conducted 16 months later 
in June 2015 (Table  6). The number of respondents 
who didn’t know what causes malaria had significantly 
dropped from 38  % (43/114) in 2014 to 23  % (25/109) 
in 2015 (p = 0.017). More respondents were aware that 
malaria symptoms include headache 36  % (40/112) in 
2014 to 51 % (54/107) in 2015 (p = 0.016) and fever 44 % 
(50/113) in 2014 to 55  % (59/107) in 2015 (p =  0.041). 
Also the percentage of respondents who understood the 
importance of all villagers participating in the MDA had 
significantly increased from 70  % (78/112) in 2014 to 
88 % (94/107) in 2015 (p = 0.001). Only the appreciation 
of asymptomatic malaria had significantly decreased 48 % 
(54/112) in 2014 to 29 % (31/107) in 2015 (p = 0.003).
Discussion
The study found that overall 83  % of respondents took 
at least three consecutive doses of anti-malarials which 
are essential to completely clear P. falciparum infections. 
The participation was highly heterogeneous from 71  % 
(in HKT) to as high as 96  % (in KNH). A range of fac-
tors was found to be associated with participation in the 
MDA. The respondents from two villages KNH and TPN 
were much more likely to participate in the MDA than 
respondents from the other two villages HKT and TOT. 
While the more compliant villages KNH and TPN gave 
the appearance of cohesive communities the villages with 
low participation TOT and HKT were unique in their 
own ways.
In TOT the community is historically divided between 
two armed factions. The village has grown together from 
two separate villages but the population remains divided. 
Uniting the population in participating in the interven-
tion has not been successful. In the absence of a cohesive 
community an intervention supported by one faction 
tends to be opposed by the other faction irrespective of 
potential benefits. The respondents from TOT gave dif-
ferent answers than the respondents from the other 
three villages suggesting different believes and percep-
tions. Their knowledge regarding the cause, signs and 
symptoms of malaria as well as their understanding of 
the intervention was significantly lower than in the other 
villages. The poor understanding of the disease as well as 
the rationale for the intervention to eliminate malaria has 
probably contributed to the low participation of respond-
ents. The MDA in 2014 had been well tolerated and no 
severe adverse events attributable to the study drugs had 
been reported which should have diffused any safety 
concerns. But there were unconfirmed rumours about 
adverse events unfairly blamed on the anti-malarial drugs 
in some parts of the village. The investigators attributed 
the continued transmission of falciparum malaria after 
the MDA to the relatively poor participation result-
ing in a residual parasite reservoir. Hence the MDA was 
repeated at the end of the 2-year surveillance period in 
2015. The study staff had a continued presence over the 
2-year surveillance period. The increased knowledge of 
malaria in 2015 compared to 2014 may reflect the impact 
of the education efforts provided by the study team. Yet 
increased knowledge and understanding did not translate 
in higher participation rates during the second MDA in 
Table 4 Perceptions of the campaign in relation to participation
The table shows the number of respondents who agree with the answer. The statistical comparison is between people who answered “yes” and people who didn’t. 
Responses are sorted by totals
* Chi squared test or Fisher’s exact test









Do you think it is important for everybody in the village to take the medicine? 16 73 % 78 81 % 125 91 % 219 86 % 0.064
Do you think you received enough information about the MDA? 6 27 % 63 66 % 112 82 % 181 71 % <0.001
Would you recommend the MDA programme to someone else? 5 23 % 58 60 % 103 75 % 166 65 % <0.001
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2015 suggesting that in TOT the historical division and 
antagonism between fractions of the population played 
a more important role in non-participation than lack of 
understanding.
The other village with low participation rates was HKT. 
HKT shares with TOT a fragmented community. The 
population of HKT has rapidly increased over the last 
decade and many of the recent arrivals consider them-
selves temporary visitors and hold different believes than 
the indigenous residents. Because they plan to stay only 
for a limited period the newcomers don’t consider them-
selves necessarily as part of the community and see lit-
tle reason to participate in a campaign, which does not 
provide direct benefits. In HKT the relatively high refusal 
rate in the MDA was associated with Burman ethnic-
ity. Specifically Burman shopkeepers felt little need to 
participate in the MDA. Participating in the campaign 
requires closing the shop for nine mornings to come to 
the healthcare centre. The absence of a direct benefit is 
hence potentially compounded by a loss of income. The 
members of the Burman minority in these tribal areas 
see themselves at low risk for malaria, are generally more 
affluent and should they become sick with malaria will 
have easier access to appropriate healthcare than the 
indigenous villagers.
An alternative, more universal reason for non-partic-
ipation in the MDA independent of village was related 
to an inadequate understanding of the intervention. 
Respondents who felt that they had received sufficient 
information were significantly more likely to participate 
than responds who felt that they didn’t know enough 
about the campaign. The perception of being well 
Table 5 Multivariate analysis of key variables associated with participation in the campaign
The most relevant key variables in each table which were statistically significant in the univariate analysis were included in the multivariate analysis
* Adjusted for village, ethnicity, do you know what causes malaria, and how did you hear about malaria—study staff
** Adjusted for village only
MDA
Less than complete Complete Total OR (univariate) OR (multivariate)*
n % n %
Number respondents 204 54 174 46 378 p value p value
Demographics of respondents
 Village
 HKT 86 70 37 30 123 1 1
 KNH 17 23 58 77 75 7.9 <0.001 17.3* 0.001*
 TOT 78 68 36 32 114 1.1 0.803 2.7* 0.2*
 TPN 23 35 43 65 66 4.4 <0.001 9.3* 0.007*
Ethnicity
 Burman 59 67 29 33 88 1 1
 Other 3 37 5 63 8 3.4 0.110 1.5* 0.6*
 Paw 42 39 66 61 108 3.2 <0.001 2.0* 0.03
 Sgaw 99 58 73 42 172 1.5 0.139 1.9* 0.08*
Profession: shop-keeper
 No 175 52 161 48 336 1 1
 Yes 29 69 13 31 42 0.5 0.041 0.6** 0.1**
Health perceptions in relation to participation: do you know what causes malaria?
 I know 160 50 157 50 317 1
 I don’t know 44 72 17 28 61 0.4 0.002 0.5* 0.05*
Perceptions of the campaign: do you think you received enough information about the MDA?
 Yes 69 38 112 62 181 1 1
 No 20 53 18 47 38 0.6 0.1 0.5** 0.07**
 Don’t know 29 81 7 19 36 0.2 <0.001 0.3** 0.01**
Would you recommend the MDA programme to someone else?
 Yes 63 38 103 62 166 1 1
 No 2 100 0 0 2 NA NA
 Don’t know 53 61 34 39 87 0.4 0.001 0.9** 0.9**
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informed about the intervention has been shown to play 
a critical role in other mass drug administrations against 
malaria [10] and other infectious diseases including lym-
phatic filariasis [14]. But there was no direct correlation 
between understanding and willingness to participate 
in the campaign. Many community members had lim-
ited understanding of the intervention or knowledge of 
malaria but still participated. On the other hand rela-
tively well informed and educated community members 
such as the shopkeepers in HKT refused to participate.
The study relied on recollection and opinions, which 
may be biased and inaccurate. The most frequent 
response to the question why they did not participate 
in the MDA was “I was travelling/I was not in the vil-
lage at the time.” This reply is more polite than stating “I 
distrust the institution conducting the campaign” even 
though distrust could have played a role in the decision 
to be absent from the campaign. To get a more detailed 
understanding of the true reasons for incomplete or non-
participation including deeper motivations, fears and 
apprehension, in-depth interviews and focus group dis-
cussions will be needed.
The biologic principles underlying the drug admin-
istrations are complex and require a relatively 
Fig. 5 Reasons for non participation given by the respondents who didn’t participate (by village, no data available for HKT)




 Mosquitoes transmit malaria 56/114 (49 %) 60/109 (55 %) 0.376
 Don’t know 43/114 (38 %) 25/109 (23 %) 0.017
What sickness causes most health problems in your village?
 Malaria 69/113 (61 %) 80/107 (75 %) 0.078
 Respiratory tract infections 15/113 (13 %) 28/107 (26 %) 0.009
What kind of complaints do people with malaria have?
 Fever 50/113 (44 %) 59/107 (55 %) 0.041
 Headache 40/112 (36 %) 54/107 (51 %) 0.016
What did you learn and understand during the sensitisation meetings?
 Many people who get malaria become sick 84/112 (75 %) 102/107 (95 %) <0.001
 Individuals can have malaria infections and feel perfectly well 54/112 (48 %) 31/107 (29 %) 0.003
 Mosquitoes may become infected from biting individuals who do not get sick 71/112 (63 %) 81/107 (76 %) 0.048
Do you think it is important for everybody in the village to take the medicine?
 Agree 78/112 (70 %) 94/107 (88 %) 0.001
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sophisticated understanding of the pathogenesis of 
malaria, the concept of a parasite reservoir and the treat-
ment of subclinical infections. These concepts are not 
easy to communicate especially over a short time period 
in a field setting to semi-literate communities few of 
whom have a secondary education. In the absence of a 
comprehensive understanding of the risks and benefits 
of the campaigns many villagers have to decide whether 
or not to participate in the campaign based on their trust 
in the study staff who have explained the intervention, 
the potential risks and benefits. Several researchers have 
explored the concept of trust in decisions whether or 
not to participate in public health interventions includ-
ing clinical trials [15–18]. Qualitative research has 
shown time and again that trust plays a central role in 
the uptake of public health interventions. Trust relation-
ships tend to be complex. In some settings it is not the 
promised indirect benefit of intervention such as the 
elimination of a disease but the tangible direct benefits 
such as free appropriate primary health care and free 
transport to a hospital in an emergency at least for the 
duration of the surveillance period [15]. In the absence 
of tangible benefits and limited comprehension of the 
broader indirect benefits for the community it is essen-
tial for the potential participant to be able to believe that 
the intervention team will act in the best interest of the 
participant. To gain such trust requires time and persis-
tent good will from both sides. The repeated campaigns 
in TOT illustrate in a fragmented community 2 years of 
permanent presence, primary health care provision and 
successful health education were not enough to increase 
participation.
Conclusions
The study found excellent participation in two cohesive 
communities. In contrast in fragmented communities 
attempts to mobilise the entire community were less 
successful. The findings suggest several approaches how 
community participation in anti-malarial mass drug 
administrations can be increased. Understanding the 
purpose and the reasons underlying the intervention is a 
helpful but perhaps not essential pre-condition for par-
ticipation. Time invested in information campaigns is a 
productive investment to increase coverage. Not only is 
the information provided critical but how this informa-
tion is communicated is essential. A sincere effort to pro-
vide honest information to community members can be 
one of several steps to build trust with the community. 
Building trust in a community is a complex, time con-
suming undertaking but only if all community members 
are convinced that they will ultimately benefit from the 
campaign can the very high participation rates achieved 
required for the elimination of infectious diseases like 
malaria. Based on the experience in one fragmented vil-
lage overcoming internal divisions within a village is 
an extraordinary challenge requiring additional time, 
engagement and repeated campaigns.
Authors’ contributions
Study design: LP, LVS, SN, FN; data management: JW; statistics: LVS; first draft: 
LVS; all authors contributed to final, submitted draft. All authors read and 
approved the final manuscript.
Author details
1 Shoklo Malaria Research Unit, Mae Sot, Thailand. 2 Mahidol Oxford Research 
Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. 3 Nuf-
field Department of Medicine, Centre for Tropical Medicine and Global Health, 
University of Oxford, Oxford, UK. 
Acknowledgements
We are indebted to the respondents in the four study villages who generously 
took the time to answer to our questions. We thank Jacqueline L. Deen for her 
suggestions and editorial support, advice from our colleagues at the Shoklo 
Malaria Research Unit and the Mahidol Oxford Research Unit specifically 
Jordi Landier, Phaik Yeong Chea, Arjen Dondorp, Nick White, and many other 
colleagues.
Competing interests
The authors declare that they have no competing interests.
Availability of data and material
Data and figures can be made available from the authors via corresponding 
author.
Consent for publication
Every participant signed a written informed consent, translated into his/her 
language.
Ethics approval and consent to participate
The study was approved by the Oxford Tropical Research Ethics Committee 
(1015-13, dated 29 Apr 2013), the Tak Border Karen Advisory Board and the 
village committees.
Funding
This work was supported by and the Wellcome Trust (reference 
101148/Z/13/Z) and the Bill & Melinda Gates Foundation (BMGF OPP1081420).
Received: 22 July 2016   Accepted: 9 September 2016
References
 1. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. 
Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl 
J Med. 2014;371:411–23.
 2. Imwong M, Hanchana S, Malleret B, Renia L, Day NP, Dondorp A, et al. 
High-throughput ultrasensitive molecular techniques for quantifying 
low-density malaria parasitemias. J Clin Microbiol. 2014;52:3303–9.
 3. Newby G, Hwang J, Koita K, Greenwood B, von Seidlein L, Shanks D, et al. 
Review of mass drug administration and primaquine use for malaria. Am 
J Trop Med Hyg. 2015;93:125–34.
 4. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. 
Mass drug administration for malaria. Cochrane Database Syst Rev. 
2013;12:CD008846.
 5. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Bjorkman A. Malaria 
eradication on islands. Lancet. 2000;356:1560–4.
 6. Atkinson JA, Vallely A, Fitzgerald L, Whittaker M, Tanner M. The archi-
tecture and effect of participation: a systematic review of community 
participation for communicable disease control and elimination. Implica-
tions for malaria elimination. Malar J. 2011;10:225.
Page 12 of 12Kajeechiwa et al. Malar J  (2016) 15:494 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 7. Zani B, Gathu M, Donegan S, Olliaro PL, Sinclair D. Dihydroartemisinin-
piperaquine for treating uncomplicated Plasmodium falciparum malaria. 
Cochrane Database Syst Rev. 2014;1:CD010927.
 8. Watanabe N, Kaneko A, Yamar S, Taleo G, Tanihata T, Lum JK, et al. A pre-
scription for sustaining community engagement in malaria elimination 
on Aneityum Island, Vanuatu: an application of Health Empowerment 
Theory. Malar J. 2015;14:291.
 9. Kaneko A. A community-directed strategy for sustainable malaria 
elimination on islands: short-term MDA integrated with ITNs and robust 
surveillance. Acta Trop. 2010;114:177–83.
 10. De Martin S, von Seidlein L, Deen JL, Pinder M, Walraven G, Greenwood B. 
Community perceptions of a mass administration of an antimalarial drug 
combination in The Gambia. Trop Med Int Health. 2001;6:442–8.
 11. Dial NJ, Ceesay SJ, Gosling RD, D’Alessandro U, Baltzell KA. A qualitative 
study to assess community barriers to malaria mass drug administration 
trials in The Gambia. Malar J. 2014;13:47.
 12. Dierickx S, Gryseels C, Mwesigwa J, O’Neill S, Bannister-Tyrell M, Ronse M, 
et al. Factors associated with non-participation and non-adherence in 
directly observed mass drug administration for malaria in The Gambia. 
PLoS One. 2016;11:e0148627.
 13. Imwong M, Nguyen TN, Tripura R, Peto TJ, Lee SJ, Lwin KM, et al. The 
epidemiology of subclinical malaria infections in South-East Asia: findings 
from cross-sectional surveys in Thailand–Myanmar border areas, Cambo-
dia, and Vietnam. Malar J. 2015;14:381.
 14. Njomo DW, Mukoko DA, Nyamongo NK, Karanja J. Increasing coverage in 
mass drug administration for lymphatic filariasis elimination in an urban 
setting: a study of Malindi Town, Kenya. PLoS One. 2014;9:e83413.
 15. Geissler PW, Kelly A, Imoukhuede B, Pool R. ‘He is now like a brother, I can even 
give him some blood’—relational ethics and material exchanges in a malaria 
vaccine ‘trial community’ in The Gambia. Soc Sci Med. 2008;67:696–707.
 16. Geissler PW, Pool R. Popular concerns about medical research projects in 
sub-Saharan Africa—a critical voice in debates about medical research 
ethics. Trop Med Int Health. 2006;11:975–82.
 17. Gilson L. Trust and the development of health care as a social institution. 
Soc Sci Med. 2003;56:1453–68.
 18. Molyneux CS, Peshu N, Marsh K. Trust and informed consent: insights 
from community members on the Kenyan coast. Soc Sci Med. 
2005;61:1463–73.
